A potent human neutralizing antibody Fc-dependently reduces established HBV infections
出版年份 2017 全文链接
标题
A potent human neutralizing antibody Fc-dependently reduces established HBV infections
作者
关键词
-
出版物
eLife
Volume 6, Issue -, Pages -
出版商
eLife Sciences Organisation, Ltd.
发表日期
2017-09-15
DOI
10.7554/elife.26738
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Future anti-HBV strategies
- (2017) Edward J. Gane LIVER INTERNATIONAL
- Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies
- (2016) Cynthia Ju et al. Cellular & Molecular Immunology
- Treatment of a patient with genotype 7 hepatitis C virus infection with sofosbuvir and velpatasvir
- (2016) Jonas Schreiber et al. HEPATOLOGY
- Antiviral effects of anti-HBs immunoglobulin and vaccine on HBs antigen seroclearance for chronic hepatitis B infection
- (2016) Masataka Tsuge et al. JOURNAL OF GASTROENTEROLOGY
- HBV replication, pathobiology and therapy: Unanswered questions
- (2016) Christoph Seeger et al. JOURNAL OF HEPATOLOGY
- Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study
- (2016) Pavel Bogomolov et al. JOURNAL OF HEPATOLOGY
- Modification of Three Amino Acids in Sodium Taurocholate Cotransporting Polypeptide Renders Mice Susceptible to Infection with Hepatitis D VirusIn Vivo
- (2016) Wenhui He et al. JOURNAL OF VIROLOGY
- HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
- (2016) Johannes F. Scheid et al. NATURE
- HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1
- (2016) T. Schoofs et al. SCIENCE
- Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo
- (2016) C.-L. Lu et al. SCIENCE
- Elimination of HIV-1-infected cells by broadly neutralizing antibodies
- (2016) Timothée Bruel et al. Nature Communications
- DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus
- (2016) Yonghe Qi et al. PLoS Pathogens
- Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells
- (2016) Hans Klingemann et al. Frontiers in Immunology
- Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy
- (2015) Cheng Sun et al. ACTA PHARMACOLOGICA SINICA
- The Hepatitis B Virus Receptor
- (2015) Wenhui Li Annual Review of Cell and Developmental Biology
- Current status of immunomodulatory therapy in chronic hepatitis B, fifty years after discovery of the virus: Search for the “magic bullet” to kill cccDNA
- (2015) Ejuan Zhang et al. ANTIVIRAL RESEARCH
- Immune-modulators to combat hepatitis B virus infection: From IFN-α to novel investigational immunotherapeutic strategies
- (2015) Nathalie Isorce et al. ANTIVIRAL RESEARCH
- Host–virus interactions in hepatitis B virus infection
- (2015) Luca G Guidotti et al. CURRENT OPINION IN IMMUNOLOGY
- Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen
- (2015) Tian-Ying Zhang et al. GUT
- Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure
- (2015) Mirjam B Zeisel et al. GUT
- Present and future therapies of hepatitis B: From discovery to cure
- (2015) T. Jake Liang et al. HEPATOLOGY
- Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis
- (2015) Anna S.F. Lok et al. HEPATOLOGY
- The role of Fc–FcγR interactions in IgG-mediated microbial neutralization
- (2015) Stylianos Bournazos et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
- (2015) Aparna Schweitzer et al. LANCET
- Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
- (2015) Marina Caskey et al. NATURE
- Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
- (2015) Jordan J. Feld et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiviral Monoclonal Antibodies: Can They Be More Than Simple Neutralizing Agents?
- (2015) Mireia Pelegrin et al. TRENDS IN MICROBIOLOGY
- Hepatitis D Virus: Introduction and Epidemiology
- (2015) Mario Rizzetto Cold Spring Harbor Perspectives in Medicine
- Viral Hepatitis: Past and Future of HBV and HDV
- (2015) E. Thomas et al. Cold Spring Harbor Perspectives in Medicine
- Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide
- (2015) Wenhui He et al. PLoS Pathogens
- NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
- (2015) Wei Wang Frontiers in Immunology
- NK cells in hepatitis B virus infection: a potent target for immunotherapy
- (2014) Ziba Shabani et al. ARCHIVES OF VIROLOGY
- Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity
- (2014) Stylianos Bournazos et al. CELL
- Hepatitis B
- (2014) Antonio Bertoletti et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Glycoengineering of Therapeutic Antibodies Enhances Monocyte/Macrophage-Mediated Phagocytosis and Cytotoxicity
- (2014) S. Herter et al. JOURNAL OF IMMUNOLOGY
- Viral Entry of Hepatitis B and D Viruses and Bile Salts Transportation Share Common Molecular Determinants on Sodium Taurocholate Cotransporting Polypeptide
- (2014) H. Yan et al. JOURNAL OF VIROLOGY
- Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo
- (2014) David J DiLillo et al. NATURE MEDICINE
- Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA
- (2014) J. Lucifora et al. SCIENCE
- Hepatitis B virus genotypes: Global distribution and clinical importance
- (2014) Mustafa Sunbul WORLD JOURNAL OF GASTROENTEROLOGY
- Chronic hepatitis B: What should be the goal for new therapies?
- (2013) Timothy M. Block et al. ANTIVIRAL RESEARCH
- Glycoengineered CD20 antibody obinutuzumab activates neutrophils and mediates phagocytosis through CD16B more efficiently than rituximab
- (2013) J. Golay et al. BLOOD
- Hepatitis B virus core protein interacts with CD59 to promote complement-mediated liver inflammation during chronic hepatitis B virus infection
- (2013) Dong Liu et al. FEBS LETTERS
- Hepatitis B virus X protein protects hepatoma and hepatic cells from complement-dependent cytotoxicity by up-regulation of CD46
- (2013) Shuai Zhang et al. FEBS LETTERS
- Myeloid cells as effector cells for monoclonal antibody therapy of cancer
- (2013) Rens Braster et al. METHODS
- Immune surveillance by the liver
- (2013) Craig N Jenne et al. NATURE IMMUNOLOGY
- NK Cells: A Double-Edged Sword in Chronic Hepatitis B Virus Infection
- (2013) Mala K. Maini et al. Frontiers in Immunology
- Tumor-Associated Macrophages Promote Invasion while Retaining Fc-Dependent Anti-Tumor Function
- (2012) K. D. Grugan et al. JOURNAL OF IMMUNOLOGY
- Crosstalk between Human IgG Isotypes and Murine Effector Cells
- (2012) M. B. Overdijk et al. JOURNAL OF IMMUNOLOGY
- HBVdb: a knowledge database for Hepatitis B Virus
- (2012) J. Hayer et al. NUCLEIC ACIDS RESEARCH
- Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
- (2012) Huan Yan et al. eLife
- An Fcγ Receptor-Dependent Mechanism Drives Antibody-Mediated Target-Receptor Signaling in Cancer Cells
- (2011) Nicholas S. Wilson et al. CANCER CELL
- Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection
- (2011) Antonio Bertoletti et al. GUT
- Hepatitis delta virus
- (2011) Sarah A Hughes et al. LANCET
- A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins
- (2011) D. Corti et al. SCIENCE
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Novel mechanism of antibodies to hepatitis B virus in blocking viral particle release from cells
- (2010) Avidan U. Neumann et al. HEPATOLOGY
- Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment
- (2010) Karl-Dimiter Bissig et al. JOURNAL OF CLINICAL INVESTIGATION
- Involvement of neutrophils and natural killer cells in the anti-tumor activity of alemtuzumab in xenograft tumor models
- (2010) William M. Siders et al. LEUKEMIA & LYMPHOMA
- Hepcidin Revisited, Disulfide Connectivity, Dynamics, and Structure
- (2009) John B. Jordan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Lytic Potential of Human Liver NK Cells Is Restricted by Their Limited Expression of Inhibitory Killer Ig-Like Receptors
- (2009) B. M. Burt et al. JOURNAL OF IMMUNOLOGY
- Primary human hepatocytes are protected against complement by multiple regulators
- (2009) Jarkko Halme et al. MOLECULAR IMMUNOLOGY
- Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
- (2009) Jianhua Sui et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells
- (2008) Kiyotaka Nakano et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage Fc RI, Fc RIII, and Fc RIV
- (2008) V. Minard-Colin et al. BLOOD
- Broadening of Neutralization Activity to Directly Block a Dominant Antibody-Driven SARS-Coronavirus Evolution Pathway
- (2008) Jianhua Sui et al. PLoS Pathogens
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation